• High Quality Sitagliptin Phosphate Monohydrate CAS 654671-77-9 Treatment of Diabetes
  • High Quality Sitagliptin Phosphate Monohydrate CAS 654671-77-9 Treatment of Diabetes
  • High Quality Sitagliptin Phosphate Monohydrate CAS 654671-77-9 Treatment of Diabetes
  • High Quality Sitagliptin Phosphate Monohydrate CAS 654671-77-9 Treatment of Diabetes
  • High Quality Sitagliptin Phosphate Monohydrate CAS 654671-77-9 Treatment of Diabetes
  • High Quality Sitagliptin Phosphate Monohydrate CAS 654671-77-9 Treatment of Diabetes

High Quality Sitagliptin Phosphate Monohydrate CAS 654671-77-9 Treatment of Diabetes

CAS No.: 654671-77-9
Formula: C16h20f6n5o6p
EINECS: 682-492-2
Type: Pharmaceutical Intermediates
Appearance: Powder
Quality: Refined
Samples:
US$ 100/Piece 1 Piece(Min.Order)
| Request Sample
Customization:
Gold Member Since 2022

Suppliers with verified business licenses

Anhui, China
Importers and Exporters
The supplier has import and export rights
High Repeat Buyers Choice
More than 50% of buyers repeatedly choose the supplier
In-stock Capacity
The supplier has In-stock capacity
Fast Delivery
The supplier can deliver the goods within 15 days
to see all verified strength labels (14)

Basic Info.

Colour
White
Transport Package
1kg/Aluminum Bag or 25kg/Drum
Specification
99% min
Trademark
Puya
Origin
China
Production Capacity
5000kilogram/Month

Product Description

High Quality Sitagliptin Phosphate Monohydrate CAS 654671-77-9 Treatment Of Diabetes

Product Name:    Sitagliptin phosphate monohydrate
Synonyms:    Sitagliptin monohydrate;Sitagliptin Phosphate.H2O;Sitagliptin Monophosphate Monohydrate;(R)-3-AMino-1-(3-(trifluoroMethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one phosphate hydrate;Sitaglipin Phosphate Monohydrate;(R)-3-amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one phosphate monohydrate;(R)-3-Amino-1-(3-(trifluor;Sitagliptin posphate monohydrate
CAS:    654671-77-9
MF:    C16H20F6N5O6P
MW:    523.3240802
EINECS:    682-492-2
Product Categories:    Inhibitors;Inhibitor;API;APIs
Mol File:    654671-77-9.mol



Sitagliptinphosphate (trade name Januvia, code MK-0431), manufactured by Merck, was approved by the U.S. Food and Drug Administration (FDA) in October 2006 for the treatment of type 2 diabetes mellitus. Sitagliptin phosphate is very effective in the treatment of type 2 diabetes. As a new type of anti-diabetic drug, sitagliptin phosphate has the advantages of blood glucose dependence, moderate hypoglycemic effect, no hypoglycemia while increasing insul in secretion, effectively reducing hunger, and no side effects such as nausea and vomiting, edema and increased body mass.

Sitagliptin Phosphate Monohydrate CAS 654671-77-9 of Chemical PropertiesFp     274.3ºC
storage temp.     2-8°C
CAS DataBase Reference    654671-77-9(CAS DataBase Reference)

Function and Application of Sitagliptin Phosphate Monohydrate CAS 654671-77-9
1. Sitagliptin Phosphate Monohydrate is a new glucose-lowering drug, dipeptidyl peptidase-4 (DPP-4) inhibitor, improves the body's own ability to lower excessive blood sugar levels
2. Sitagliptin Phosphate Monohydrate is a dipeptidyl peptidase-IV (DPPIV) inhibitor.


Packing And Shipping
1.Preferentially DHL, FedEX or TNT for quantity less than 50kg, air shipping for 100kg above, sea shipping for quantity over 500kg.
2.For customers from Russia,Mexico,Turkey,Solvenia,Romania,etc,before placing an order,please kindly confirm if you can make clearance when goods reach your customs.
Shipping Terms
By Express By Air By Sea
Suitable for under 50kg
Fast:3-4 days
High cost
Door to door service
Easy to pick up the goods
Suitable for more than 50kg
Fast:3-4 days
High cost
Airport to airport
Professional broker needed
Suitable for more than 500kg
Slow:15-30 days
Low cost
Port to port
Professional broker needed

High Quality Sitagliptin Phosphate Monohydrate CAS 654671-77-9 Treatment of Diabetes
 

High Quality Sitagliptin Phosphate Monohydrate CAS 654671-77-9 Treatment of Diabetes
Company Profile
Anhui puya biological technology co.,ltd was established in Hefei. Registered capital is 5 million. It is specialized in manufacture plant extract, API and chemicals raw material powder, food additives and oil. which are applied to skin care, healthcare, weight loss products, sex improvement, and pharmaceuticals. We will uphold honesty and pragmatic, innovative and enterprising service purposes, and provide a variety of quality services to our customers at abroad. It aims at supplying good product and comfort service. The strict quality control is to meet the customer's requirement, to get a highly praised and to be high quality supplier. If you have any question, or need samples, please feel free to contact us.
High Quality Sitagliptin Phosphate Monohydrate CAS 654671-77-9 Treatment of Diabetes

FAQ
Q1. What's the MOQ?
A: Usually 1 kg.  It is based on the different product. Some are 1g and some are 1 ton. Please be free to consult our salesman.
 
Q2. What's the shipping time?
A: If in stock, we will ship it out immediately.  By FedEx will be 3~5 days to you.
 
Q3. If I need less than the MOQ, is it possible?
A: Yes. Please be free to consult our salesman.
 
Q4. Can you supply the free sample?
A: Usually it is possible. but the shipping cost be paid by customers. It based on the different product. Please be free to consult our salesman.
 
Q5. How to store the product?
A: Store in cool and dry place. It must be in well closed containers. The shelf life will be 2 years.
 
Q6: What's your main payment method?
A: T/T, trade assurance, west union, money gram.
 
Q7: Do you have COA, MSDS, CO, Health certificate, form 9 or other certificate?
A: Yes, we have. pls be free to contact us to get updated one.

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Gold Member Since 2022

Suppliers with verified business licenses

Trading Company
Number of Employees
3
Year of Establishment
2023-04-18